SYNCOM FORMULATIONS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 inter alia to consider and approve 1. To consider & approve the Standalone Audited financial results of the Company for the Quarter/Year ended 31st March 2021.
2. To take on record the Audit Report of the Statutory Auditors for the Standalone Audited Financial Results of the Company for the Quarter/Year ended 31st March 2021.
3. To consider and approve the Standalone Audited Financial Statements including the Balance Sheet as at 31st March 2021 and the Statement of Profits and Loss and Cash flow statement of change in equity and notes thereon for the year ended 31st March 2021.
वैल्यू रिसर्च से पूछें 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
